Physician

John R. Zade, M.D.

According to 2025 Medicare claims, John Zade, M.D. (NPI: 1962931964) practices dermatology in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is CENTER FOR DERMATOLOGY, PLLC (NPI: 1194792416; TIN: 861004041) and primary practice location at 85364-8347. Zade is affiliated with the Arizona Health Advantage, Inc (ACO ID: D0006), participating under the REACH model.

Zade's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 981 traditional Medicare patients, billed 5,933 HCPCS/CPT codes, and received $596,148 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 1,515 prescription claims across 757 beneficiaries totaling $58,846 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 35 records totaling $758. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,554 and ending at $58,846. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$298K$596K2021 Medicare payment: $165,592 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $198,696 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $353,831 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $596,148 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213993,051$165,592
20225913,425$198,696
20234862,612$353,831
20249815,933$596,148

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$201K$401K2017 Drug cost: $1,554 (USD; Tot_Drug_Cst)2018 Drug cost: $4,575 (USD; Tot_Drug_Cst)2019 Drug cost: $3,169 (USD; Tot_Drug_Cst)2020 Drug cost: $1,551 (USD; Tot_Drug_Cst)2021 Drug cost: $108,858 (USD; Tot_Drug_Cst)2022 Drug cost: $401,058 (USD; Tot_Drug_Cst)2023 Drug cost: $47,131 (USD; Tot_Drug_Cst)2024 Drug cost: $58,846 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171560$1,554
20183481$4,575
20192670$3,169
2020N/R22$1,551
2021226501$108,858
2022399985$401,058
20234691,071$47,131
20247571,515$58,846

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more272272$78
11102Biopsy of related skin growth, first growth338407$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more441593$63
17000Destruction of precancer skin growth, 1 growth419523$39
17003Destruction of precancer skin growth, 2-14 growths3242,045$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole3069,783$6,745
Clobetasol PropionateClobetasol Propionate1113,163$3,496
Doxycycline HyclateDoxycycline Hyclate4795,613$3,151
TacrolimusTacrolimus361,215$2,878
Triamcinolone AcetonideTriamcinolone Acetonide1766,046$2,288

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$758ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John R. Zade, M.D.?

Tedicare shows public-source Medicare data for John R. Zade, M.D. (NPI 1962931964), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John R. Zade, M.D. have ACO affiliation data?

John R. Zade, M.D. is shown with ACO affiliation data for Arizona Health Advantage, Inc (REACH, ACO ID D0006).

What billing organization is linked to John R. Zade, M.D.?

John R. Zade, M.D. is linked to CENTER FOR DERMATOLOGY, PLLC (billing NPI 1194792416) in the available physician profile data.

Does John R. Zade, M.D. have Open Payments data?

John R. Zade, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.